Rare diseases
Investigational molecules
Locations
Back to France646 clinical trials in Rouen, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
FranceStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
FranceStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
FranceStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
FranceStudy on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure
FranceStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceA Study of Setidegrasib with Chemotherapy Drug Combination as First‑Line Treatment in Adults with KRAS G12D‑mutated Metastatic Pancreatic Cancer
FrancePhase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
FranceEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
FranceCabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy
FrancePhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
FrancePhase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancers, including head and neck squamous cell carcinoma, bladder cancer, and breast cancer. Studies are evaluating novel therapeutic combinations and targeted approaches.
Multiple studies are investigating new drug combinations and personalized treatment approaches.
Research initiatives examining treatments for Alzheimer's disease, frontotemporal dementia, and multiple sclerosis. Studies focus on understanding disease mechanisms and testing novel therapeutic approaches.
Innovative approaches using advanced imaging and biomarker analysis are being explored.
Studies investigating treatments for heart failure prevention and pulmonary hypertension. Research includes evaluation of new therapeutic agents and combination treatments.
Focus on developing safer and more effective cardiovascular treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
